Related Experiment Video
Updated: Mar 23, 2026
07:14
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
615
Antimalarial drug resistance: An overview
Hiasindh Ashmi Antony1, Subhash Chandra Parija1
1Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Tropical Parasitology
|March 22, 2016
Summary
Antimalarial drug resistance threatens malaria control efforts. Understanding drug mechanisms and monitoring resistance through various tests are crucial for effective malaria treatment policies and combating resistant parasites.
Area of Science:
- * Public Health
- * Infectious Diseases
- * Pharmacology
Background:
- * Malaria remains a significant global public health challenge, causing widespread mortality and morbidity.
- * Increasing resistance to antimalarial drugs jeopardizes progress in malaria control programs.
- * Understanding drug resistance mechanisms is vital for developing effective treatment strategies.
Purpose of the Study:
- * To review commonly used antimalarial drugs and their mechanisms of action.
- * To summarize validated genetic markers for detecting antimalarial drug resistance.
- * To highlight the importance of monitoring drug resistance for informed policy-making.
Main Methods:
- * Literature review of antimalarial drugs, mechanisms, and resistance markers.
- * Analysis of in vivo efficacy studies and in vitro drug susceptibility tests.
- * Examination of molecular markers associated with drug resistance.
Main Results:
- * Detailed summary of established antimalarial drugs and their pharmacodynamics.
- * Identification of key genetic markers linked to resistance against various antimalarials.
- * Emphasis on the role of monitoring in guiding antimalarial drug policies.
Conclusions:
- * Antimalarial drug resistance is a growing threat requiring continuous monitoring.
- * Understanding drug mechanisms and resistance markers is essential for effective malaria treatment.
- * Integrated surveillance strategies are necessary to combat drug-resistant malaria parasites.
More Related Videos
10:22Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
9.4K
10:27Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria
Published on: November 10, 2015
12.2K
Related Concept Videos
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
01:15Anthelminthic Agents
37
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
37
01:31ABC Transporters: Exporter
7.1K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
7.1K
01:25Mechanism of Antibiotic Resistance in MRSA
47
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
47
01:16Therapeutic Drug Monitoring: Overview and Classification
506
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
506
01:29Therapeutic Drug Monitoring: Affecting Factors
323
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
323